New-onset diabetes in COVID-19: A literature review
By: N. P. Nugroho, H. Novida and S. P. Hapsari
Open Access
|Jun 2022Abstract
COVID-19 has become a major global health problem. COVID-19 teaches us many things, one of which is the relationship between COVID-19 and diabetes. Recent evidence suggests that the coronavirus may cause diabetes. In addition, the term new-onset diabetes in COVID-19 was introduced in 2020, and evidence has been reported. It poses a new challenge to the clinical management of COVID-19 patients. The pathophysiology of this disease is still not fully known. However, hypotheses have been proposed. Therefore, we write this literature review to add insight into new-on set diabetes in COVID-19 patients.
DOI: https://doi.org/10.4038/sjdem.v12i1.7449 | Journal eISSN: 2012-998X
Language: English
Page range: 31 - 39
Published on: Jun 28, 2022
Published by: Sri Lanka College of Endocrinologists
In partnership with: Paradigm Publishing Services
Keywords:
© 2022 N. P. Nugroho, H. Novida, S. P. Hapsari, published by Sri Lanka College of Endocrinologists
This work is licensed under the Creative Commons License.